Sojourn time, sensitivity and positiva predictive value of mammography screening for breast cancer in women aged 40-49

International Journal of Epidemiology

Volumn 25, Issue 6, 1996, Pages 1139-1145

  Duffy, S W ^a   Chen, H H ^a   Tabar, Laszlo ^b   Fagerberg, Gunnar ^c   Paci, Eugenio ^d  

^a MRC BIOSTATISTICS UNIT   (United Kingdom)

^b FALUN HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^d CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

Author keywords

Breast cancer screening; Positive predictive value; Sensitivity; Sojourn time

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAMMOGRAPHY; MODEL; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TECHNIQUE;

ADULT; BREAST NEOPLASMS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SWEDEN; TIME FACTORS;

EID: 0030456246     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/25.6.1139     Document Type: Article

References (11)

1. Tabar L, Fagerberg G, Duffy S W, Day N E, Gad A, Grontfot O. Update of the Swedish Two-County program of mammographic screening for breast cancer. Radiol Clin N Am 1992; 30: 187-210.
2. Nystrom L, Rutqvist L E, Wall S, Lindgren A, Lindqvist M, Ryden S et al. Breast cancer screening with mammography: an overview of the Swedish randomised trials. Lancet 1993; 341: 973-78.
3. Tabar L, Fagerberg C J G, Chen H H et al. Efficacy of breast cancer screening by age: New results from Swedish Two-County trial. Cancer 1995; 75: 2507-17.
4. Paci E, Duffy S W. Modelling the analysis of breast cancer screening programmes: Sensitivity, lead time and predictive value in the Florence District Programme (1975-1986). Int J Epidemiol 1991; 20: 852-58.
5. Day N E. Estimating the sensitivity of a screening test. J Epidemiol Community Health 1985; 39: 364-66.
6. Day N E, Walter S D. Simplified methods of screening for chronic disease: estimation procedure from mass screening programme. Biometrics 1984; 40: 1-14.
7. Walter S D, Day N E. Estimation of the duration of a preclinical state using screening data. Am J Epidemiol 1983; 118: 865-86.
8. Muir C S, Waterhouse J, Mack T, Powell J, Whelan S L. Cancer Incidence in Five Continents, Vol. V. Lyon: IARC, 1987.
9. Parkin D M, Muir C S, Whelan S L, Gao Y T, Felang J, Powell J. Cancer Incidence in Five Continents, Vol. VI. Lyon: IARC, 1992.
10. Duffy S W, Chen H H, Tabar L, Day N E. Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase. Stat Med 1995; 14: 1531-43.
11. Chen H H, Duffy S W, Tabar L. A Markov chain method to estimate the tumour progression rate from preclinical to clinical phase, sensitivity and positive predictive value for mammography in breast cancer screening. The Statistician (In press).